Your Smart Companion for GLP-1 Success
Glapp helps you optimize your therapy, minimize side effects, and sustain long-term results — through clear, supportive, evidence-informed guidance.
Trusted by GLP-1 users and recommended by clinical specialists.
Our Mission
To make GLP-1 therapy effortless, safe, and effective for everyone.
GLP-1 medications are powerful, but the experience can feel uncertain: dose timing, plateaus, hunger return, side effects, and long-term maintenance often confuse even the most motivated users.
Glapp was created to replace that confusion with clarity.
Why We Exist
Obesity is a global health epidemic, and for many people GLP‑1 therapy is the first tool that finally works.
Yet most GLP‑1 patients still navigate treatment alone, relying on guesswork or scattered advice from online forums.
Glapp was founded in 2025 by GLP‑1 users and health‑tech professionals who believe people deserve better — reliable support, structured guidance, and an intelligent companion built specifically for the GLP‑1 journey.
Glapp provides just that: a clearer path forward, week after week.
Science behind Glapp
Glapp is built on GLP‑1 science, not guesswork. Every major feature starts from clinical evidence on how these medications work, their benefits, and their risks.
- Evidence‑driven foundation — We ground our product in peer‑reviewed research on GLP‑1 benefits, side effects, dosing, and long‑term outcomes.
- Always up to date — We continuously review new studies, guidelines, and real‑world data so Glapp reflects the latest understanding of GLP‑1 therapy.
- Clinician‑informed design — We collaborate with medical doctors to review key features and educational content for safety, accuracy, and real‑world usefulness. Glapp isn't a doctor, but it's built with clinicians at the table.
A Word From the Clinical Community
"Glapp is the favorite app of our patients.
"
Dr. Spencer Nadolsky
Obesity & Lipid Specialist, Founder of The Vineyard
Our Team
We are a team of health-tech professionals with a long track record of building trusted digital health products — and GLP-1 users ourselves.
Our strength comes from four things:
- Strong product and engineering expertise
- A long track record in health-tech and med-tech
- Medical input from trusted experts
- Direct lived experience with GLP-1
Contact Us
Company
Glapp is built and operated by Glapp, Inc., a U.S.-based company focused on digital tools for GLP‑1 therapy.
Headquarters: Dover, Delaware, USA